• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

View Calendar

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Glen Elison, USA

    Glen Elison, USA

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Mike Small, UK

    Mike Small, UK

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Bayley, Australia

    Bayley, Australia

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • David Watson, Scotland

    David Watson, Scotland

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Willi Klein, UK

    Willi Klein, UK

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Lee Millard, England

    Lee Millard, England

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Rob Tison, USA

    Rob Tison, USA

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Ann Nicol, USA

    Ann Nicol, USA

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • JP

    JP

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Jason Goodman, USA

    Jason Goodman, USA

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Len Johnrose, England

    Len Johnrose, England

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Purningam Jacob, India

    Purningam Jacob, India

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Jon Newsome, USA

    Jon Newsome, USA

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login